Free Trial

Evolent Health (EVH) News Today

Evolent Health logo
$10.44 -0.27 (-2.51%)
Closing price 02/21/2025 03:59 PM Eastern
Extended Trading
$10.58 +0.13 (+1.28%)
As of 02/21/2025 06:42 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Evolent Health price target lowered to $16 from $17 at Piper Sandler
Oppenheimer Remains a Buy on Evolent Health (EVH)
JMP Securities Keeps Their Buy Rating on Evolent Health (EVH)
Evolent Health, Inc. stock logo
Evolent Health (NYSE:EVH) Issues Earnings Results
Evolent Health (NYSE:EVH - Get Free Report) issued its quarterly earnings data on Thursday. The technology company reported $0.03 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.38 by ($0.35). Evolent Health had a negative net margin of 2.93% and a positive return on equity of 6.30%.
KeyBanc Sticks to Their Buy Rating for Evolent Health (EVH)
Evolent Health misses Q4 estimates, shares drop on weak guidance
Evolent Health reports Q4 EPS (2c), consensus 1c
Evolent Health sees Q1 revenue $440M-$447M, consensus $592.1M
Evolent Health (NYSE:EVH) Misses Q4 Sales Targets
Evolent Health, Inc. (EVH) Q4 2024 Earnings Call Transcript
Evolent Announces Fourth Quarter and Full Year 2024 Results
Evolent Health (EVH) Q4 Earnings Report Preview: What To Look For
Evolent Health, Inc. stock logo
Peregrine Capital Management LLC Has $5.67 Million Stock Position in Evolent Health, Inc. (NYSE:EVH)
Peregrine Capital Management LLC raised its stake in Evolent Health, Inc. (NYSE:EVH - Free Report) by 65.0% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 503,601 shares of the technology company's stock aft
Evolent Health, Inc. stock logo
Congress Asset Management Co. Purchases 120,261 Shares of Evolent Health, Inc. (NYSE:EVH)
Congress Asset Management Co. increased its holdings in Evolent Health, Inc. (NYSE:EVH - Free Report) by 115.6% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 224,284 shares of the tech
Evolent Health, Inc. stock logo
Evolent Health (NYSE:EVH) Given Market Outperform Rating at JMP Securities
JMP Securities reiterated a "market outperform" rating and set a $12.00 price objective on shares of Evolent Health in a research note on Friday.
Evolent Health, Inc. stock logo
Evolent Health, Inc. (NYSE:EVH) Receives Consensus Recommendation of "Buy" from Brokerages
Evolent Health, Inc. (NYSE:EVH - Get Free Report) has been assigned a consensus recommendation of "Buy" from the thirteen ratings firms that are covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a hold rating, eleven have assigned a buy ratin
Evolent Health, Inc. stock logo
Evolent Health, Inc. (NYSE:EVH) Shares Acquired by Entropy Technologies LP
Entropy Technologies LP raised its position in Evolent Health, Inc. (NYSE:EVH - Free Report) by 247.6% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 39,219 shares of the technology company's stock after acquiring an
Evolent Health, Inc. stock logo
Evolent Health (EVH) Expected to Announce Earnings on Thursday
Evolent Health (NYSE:EVH) will be releasing earnings after the market closes on Thursday, February 20. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=659615)
Evolent Health, Inc. stock logo
Evolent Health's (EVH) "Buy" Rating Reiterated at Needham & Company LLC
Needham & Company LLC reiterated a "buy" rating and issued a $15.00 price target on shares of Evolent Health in a report on Wednesday.
Evolent Health, Inc. stock logo
Evolent Health (NYSE:EVH) Reaches New 12-Month Low - Time to Sell?
Evolent Health (NYSE:EVH) Reaches New 52-Week Low - Time to Sell?
Evolent Health, Inc. stock logo
Evolent Health (NYSE:EVH) Hits New 52-Week Low - Time to Sell?
Evolent Health (NYSE:EVH) Reaches New 52-Week Low - Time to Sell?
Evolent Health, Inc. stock logo
William Blair Reduces Earnings Estimates for Evolent Health
Evolent Health, Inc. (NYSE:EVH - Free Report) - Investment analysts at William Blair cut their Q4 2024 earnings per share (EPS) estimates for Evolent Health in a research note issued on Thursday, January 30th. William Blair analyst R. Daniels now expects that the technology company will earn ($0.
Evolent Health, Inc. stock logo
FY2024 EPS Estimates for Evolent Health Lowered by Analyst
Evolent Health, Inc. (NYSE:EVH - Free Report) - William Blair cut their FY2024 earnings estimates for Evolent Health in a research report issued on Monday, January 27th. William Blair analyst R. Daniels now anticipates that the technology company will post earnings of $0.21 per share for the year
Evolent Health, Inc. stock logo
Evolent Health (NYSE:EVH) Trading 6.7% Higher - Time to Buy?
Evolent Health (NYSE:EVH) Stock Price Up 6.7% - Here's What Happened
Evolent Health, Inc. stock logo
JPMorgan Chase & Co. Issues Pessimistic Forecast for Evolent Health (NYSE:EVH) Stock Price
JPMorgan Chase & Co. dropped their price target on Evolent Health from $15.00 to $13.00 and set an "overweight" rating on the stock in a research note on Tuesday.
Evolent Health price target lowered to $12 from $18 at JMP Securities
Evolent Health (EVH) Receives a Buy from JMP Securities
Evolent Health, Inc. stock logo
Oppenheimer Cuts Evolent Health (NYSE:EVH) Price Target to $18.00
Oppenheimer reduced their price target on shares of Evolent Health from $28.00 to $18.00 and set an "outperform" rating for the company in a report on Friday.
Evolent Health, Inc. stock logo
Evolent Health (NYSE:EVH) Shares Gap Down After Analyst Downgrade
Evolent Health (NYSE:EVH) Shares Gap Down After Analyst Downgrade
Evolent Health, Inc. stock logo
Brighton Jones LLC Acquires New Holdings in Evolent Health, Inc. (NYSE:EVH)
Brighton Jones LLC acquired a new position in shares of Evolent Health, Inc. (NYSE:EVH - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 349,109 shares of the technology company's stock, valued at appro
Evolent Health price target lowered to $16 from $23 at Canaccord
Evolent Health, Inc. stock logo
Canaccord Genuity Group Issues Pessimistic Forecast for Evolent Health (NYSE:EVH) Stock Price
Canaccord Genuity Group cut their price target on shares of Evolent Health from $23.00 to $16.00 and set a "buy" rating on the stock in a report on Thursday.
Evolent Health price target lowered to $20 from $29 at BTIG
Get Evolent Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for EVH and its competitors with MarketBeat's FREE daily newsletter.

EVH Media Mentions By Week

EVH Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

EVH
News Sentiment

0.33

0.64

Average
Computer and Technology
News Sentiment

EVH News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

EVH Articles
This Week

25

5

EVH Articles
Average Week

Get Evolent Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for EVH and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NYSE:EVH) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners